Platform Technology Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.17M Sell
20,385
-1,132
-5% -$65K 0.19% 109
2026
Q1
$1.3M Buy
21,517
+1,293
+6% +$75.4K 0.25% 92
2025
Q4
$1.09M Sell
20,224
-1,767
-8% -$85K 0.23% 98
2025
Q3
$992K Sell
21,991
-1,274
-5% -$59.5K 0.24% 101
2025
Q2
$1.08M Sell
23,265
-273
-1% -$13.4K 0.28% 90
2025
Q1
$1.44M Sell
23,538
-652
-3% -$38K 0.42% 65
2024
Q4
$1.37M Buy
24,190
+67
+0.3% +$3.74K 0.41% 62
2024
Q3
$1.25M Sell
24,123
-1,113
-4% -$52.2K 0.39% 70
2024
Q2
$1.05M Buy
+25,236
New +$1.13M 0.36% 72
2023
Q4
$1.34M Buy
26,906
+2,908
+12% +$153K 0.52% 58
2023
Q3
$1.39M Sell
23,998
-318
-1% -$19.5K 0.65% 43
2023
Q2
$1.53M Sell
24,316
-693
-3% -$46.5K 0.72% 36
2023
Q1
$1.73M Sell
25,009
-420
-2% -$29.6K 0.86% 32
2022
Q4
$1.83M Buy
25,429
+304
+1% +$22.9K 0.95% 26
2022
Q3
$1.79M Sell
25,125
-372
-1% -$27K 1.02% 22
2022
Q2
$1.96M Sell
25,497
-258
-1% -$19.6K 1.07% 22
2022
Q1
$1.88M Sell
25,755
-398
-2% -$26.7K 0.9% 22
2021
Q4
$1.63M Sell
26,153
-569
-2% -$33.4K 0.72% 30
2021
Q3
$1.58M Sell
26,722
-1,959
-7% -$129K 0.72% 31
2021
Q2
$1.92M Buy
+28,681
New +$1.87M 0.79% 21
2020
Q4
$2.03M Buy
32,741
+127
+0.4% +$7.81K 0.99% 16
2020
Q3
$1.97M Buy
32,614
+1,632
+5% +$98.2K 1.2% 14
2020
Q2
$1.82M Buy
30,982
+1,308
+4% +$78.2K 1.28% 14
2020
Q1
$1.65M Buy
29,674
+4,323
+17% +$264K 1.51% 13
2019
Q4
$1.63M Buy
+25,351
New +$1.45M 1.23% 15

Other funds holding BMY

Platform Technology Partners's BMY Position: Q2 2026 in Review

Platform Technology Partners reduced its Bristol-Myers Squibb (BMY) stake by 5.3% in Q2 2026, selling an estimated $65K and leaving 20,385 shares worth $1.17M. The position accounts for 0.19% of the portfolio, ranked #109.

Platform Technology Partners first reported a position in BMY in Q4 2019 and has held it in 25 quarters since. The position peaked at $2.03M in Q4 2020. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Platform Technology Partners held 20,385 shares of Bristol-Myers Squibb worth $1.17M as of Q2 2026.
  • Platform Technology Partners sold 1,132 Bristol-Myers Squibb shares in Q2 2026, an estimated $65K.
  • Bristol-Myers Squibb made up 0.19% of Platform Technology Partners's portfolio in Q2 2026, its #109 holding.
  • Platform Technology Partners first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 25 quarters since.
  • Platform Technology Partners's Bristol-Myers Squibb position peaked at $2.03M in Q4 2020.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Platform Technology Partners's 13F filing for Q2 2026, filed 24 Jul 2026.